These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26092709)

  • 21. [Triple-negative breast carcinoma--rewiev of current literature].
    Rubovszky G; Udvarhelyi N; Horváth Z; Láng I; Kásler M
    Magy Onkol; 2010 Dec; 54(4):325-35. PubMed ID: 21163763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X; Ying J; Wang F; Wang J; Yang H
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related frequency of triple negative breast cancer in women.
    Sajid MT; Ahmed M; Azhar M; Mustafa QU; Shukr I; Ahmed M; Kamal Z
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):400-3. PubMed ID: 24953912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers.
    Abd El-Hafez A; Shawky Mohamed Ael-A; Elesawy BH
    Asian Pac J Cancer Prev; 2013; 14(2):1037-41. PubMed ID: 23621182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triple-negative breast cancer: advancements in characterization and treatment approach.
    Hurvitz S; Mead M
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):59-69. PubMed ID: 26694831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic triple-negative breast cancer.
    Rakha EA; Chan S
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):587-600. PubMed ID: 21524569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Breast cancer with triple-negative phenotype in the Russian patient population. Clinical and morphologic features].
    Zhukova LG
    Vopr Onkol; 2015; 61(2):189-94. PubMed ID: 26087596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
    Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
    Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Directed therapy of subtypes of triple-negative breast cancer.
    Carey LA
    Oncologist; 2011; 16 Suppl 1():71-8. PubMed ID: 21278443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple negative breast cancer: the kiss of death.
    Jitariu AA; Cîmpean AM; Ribatti D; Raica M
    Oncotarget; 2017 Jul; 8(28):46652-46662. PubMed ID: 28445140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.
    Yu J; Gao F; Klimberg VS; Margenthaler JA
    Ann Surg Oncol; 2012 Oct; 19(10):3159-64. PubMed ID: 22878611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Lox in triple-negative breast cancer.
    Leo C; Cotic C; Pomp V; Fink D; Varga Z
    Ann Diagn Pathol; 2018 Jun; 34():98-102. PubMed ID: 29661738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promising therapeutic options in triple-negative breast cancer.
    Bilici A; Arslan C; Altundag K
    J BUON; 2012; 17(2):209-22. PubMed ID: 22740196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.
    Rambau P; Masalu N; Jackson K; Chalya P; Serra P; Bravaccini S
    BMC Res Notes; 2014 Jun; 7():399. PubMed ID: 24964871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns.
    Cadoo KA; Fornier MN; Morris PG
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):312-21. PubMed ID: 24322788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate receptor α associated with triple-negative breast cancer and poor prognosis.
    Zhang Z; Wang J; Tacha DE; Li P; Bremer RE; Chen H; Wei B; Xiao X; Da J; Skinner K; Hicks DG; Bu H; Tang P
    Arch Pathol Lab Med; 2014 Jul; 138(7):890-5. PubMed ID: 24028341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple negative breast cancer: therapeutic and prognostic implications.
    Brady-West DC; McGrowder DA
    Asian Pac J Cancer Prev; 2011; 12(8):2139-43. PubMed ID: 22292666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].
    Ma JG; Wang NJ; Yu WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1729-32. PubMed ID: 22027778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.